Physician profile

Natalie Soszyn

Aurora, CO

NPI 1245967785

$3,110.82

in general payments reported to CMS, 2019-2025

5 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,854.80
Travel and Lodging$1,244.14

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Edwards Lifesciences Corporation $1,480.23 2022-2024 Edwards Sapien 3 Transcatheter Heart Valve (Thv), The Edwards Sapien 3 Valve With Alterra Adaptive Prestent System, Edwards Sapien 3 Ultra Transcatheter Heart Valve
Abbott Laboratories $627.11 2023-2024 Piccolo Xpress, Amplatzer, Amplatzer Amulet
Medtronic, INC. $491.71 2023-2024 Harmony
Terumo Medical Corporation $273.94 2024 Azur Cx Detachable, Progreat, Glidesheath Slender
Penumbra, INC. $237.83 2023-2024 Indigo System

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Natalie Soszyn

$3,110.82

in general payments reported 2019-2025

Years
2022-2024
Top company
Edwards Lifesciences Corporation

https://glasscript.com/doctor/11429317/natalie-soszyn

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.